Skip to main content

Table 5 Cases with clot retention in AP/AC continuation group

From: Risks and complications of transurethral resection of bladder tumors in patients receiving antiplatelet and/or anticoagulant therapy: a retrospective cohort study

 

Sex

Medication

Tumor no.

Tumor size (cm)

pT stage

POD at catheter removal

Onset of clot retention (POD)

Treatment

Case 1

M

Aspirin

2

1.5

a

(−)

1

Surgical reinterventiom

Case 2

M

Aspirin

2

3

1

(−)

3

Surgical reinterventiom

Case 3

M

Aspirin

1

2

1

1

21

Bladder drainage

Case 4

M

Aspirin

6

2

1

2

3

Bladder drainage and irrigation

  1. AP antiplatelet agents, AC anticoagulant agents, no number, POD postoperative day, M male